Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bowel preparation before large bowel resection
2015-004559-38Phase 4Completed
- Sponsor
- HUS Abdominal Center
- Start
- Dec 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of neomycin, metronidazole and macrogol in Colorectal disease, sponsored by HUS Abdominal Center. Primary endpoint: Surgical site infection within 30 days from large bowel resection. Started Dec 2015; status: completed.
02
Drugs
neomycinmetronidazolemacrogol
03
Conditions
Colorectal disease
Beyond the preview
Go deeper on 2015-004559-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004559-38.